Quick Takeaways
- Woodline Partners LP filed SCHEDULE 13G/A for Tango Therapeutics, Inc. Common Stock, par value $0.001 per share (TNGX).
- Disclosed ownership: 7.5%.
- Date of event: 31 Dec 2025.
Woodline Partners LP - 31 Dec 2025 SCHEDULE 13G/A Report for Tango Therapeutics, Inc. Common Stock, par value $0.001 per share (TNGX)
- Filing Manager
- Woodline Partners LP
- Reporting Manager
- Woodline Partners LP
- Symbol
- TNGX
- Shares outstanding
- 134,296,333 shares
- Disclosed Ownership
- 10,072,225 shares
- Ownership
- 7.5%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 15:22:25 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Woodline Partners LP disclosed 7.5% ownership in Tango Therapeutics, Inc. Common Stock, par value $0.001 per share (TNGX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Aug 2025.
- Current filing was accepted on 17 Feb 2026, 15:22.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Woodline Partners LP | 7.5% | 10,072,225 | 10,072,225 | 0 | /s/ Erin Mullen | Erin Mullen, General Counsel & Chief Compliance Officer |